Similac, Pediasure Drive Abbott’s Ross Sales In 2007
This article was originally published in The Tan Sheet
Executive Summary
Similac, PediaSure and the launch of NutriPals bars and shakes drove sales by Abbott Laboratories' Ross U.S. Nutritionals unit up 3 percent to $624 million in its fourth quarter, according to Abbott President and COO Rick Gonzalez